Issued Patents All Time
Showing 1–9 of 9 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9844542 | Substituted imidazopyridine and triazolopyridine compounds as negative allosteric modulators of mGluR5 | Kyle A. Emmitte, Craig W. Lindsley, P. Jeffrey Conn, Andrew S. Felts, Katrina A. Smith +1 more | 2017-12-19 |
| 9085562 | 6-alkyl-N-(pyridin-2-yl)-4-aryloxypicolinamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same | P. Jeffrey Conn, Craig W. Lindsley, Kyle A. Emmitte, Andrew S. Felts, Carrie K. Jones +2 more | 2015-07-21 |
| 8853392 | Benzamide mGluR5 positive allosteric modulators and methods of making and using same | P. Jeffrey Conn, Craig W. Lindsley, Charles David Weaver, Colleen M. Niswender, Carrie K. Jones +1 more | 2014-10-07 |
| 8796295 | Substituted benzamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same | P. Jeffrey Conn, Craig W. Lindsley, Kyle A. Emmitte, Charles David Weaver, Andrew S. Felts +2 more | 2014-08-05 |
| 8598345 | Substituted heteroarylamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same | P. Jeffrey Conn, Craig W. Lindsley, Kyle A. Emmitte, Charles David Weaver, Andrew S. Felts +2 more | 2013-12-03 |
| 8569308 | Substituted heteroarylamine carboxamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same | P. Jeffrey Conn, Craig W. Lindsley, Kyle A. Emmitte, Charles David Weaver, Andrew S. Felts +2 more | 2013-10-29 |
| 8501757 | Substituted phenylamine carboxamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same | P. Jeffrey Conn, Craig W. Lindsley, Kyle A. Emmitte, Charles David Weaver, Andrew S. Felts +3 more | 2013-08-06 |
| 8034806 | Bicyclic mGluR5 positive allosteric modulators and methods of making and using same | P. Jeffrey Conn, Craig W. Lindsley, Charles David Weaver, Colleen M. Niswender, Carrie K. Jones +1 more | 2011-10-11 |
| 7531541 | Partial mGluR5 antagonists for treatment of anxiety and CNS disorders | P. Jeffrey Conn, Carrie K. Jones | 2009-05-12 |